Summit Therapeutics Inc. (SMMT) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Summit Therapeutics Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.680 Hello and welcome to the Summit Therapeutics Q1 2025 earnings 00:00:05.680 -- 00:00:10.848 conference call. I would now like to turn the call over to our Chief Business and Strategy 00:00:10.848 -- 00:00:14.875 Officer, Dave Van Kars. Please go ahead, sir. 00:00:14.875 -- 00:00:17.479 Good afternoon and thank you for joining us. 00:00:17.479 -- 00:00:21.586 A press release was issued earlier this afternoon and is available on the homepage of 00:00:21.586 -- 00:00:26.714 our website. Our Form 10Q was also filed and is available 00:00:26.714 -- 00:00:31.723 on our website. Today's call is being simultaneously webcast and an archived 00:00:31.723 -- 00:00:37.727 replay will also be made available later today on our website, www.smmttx.com. 00:00:41.554 -- 00:00:45.838 Joining me on the call today is Bob Duggan, our chairman of the board and co-chief executive 00:00:45.838 -- 00:00:51.044 officer. Dr. Maki Zangane, our co-chief executive officer and president. 00:00:51.044 -- 00:00:55.388 Manmeet Soni, our chief operating officer and chief financial officer. 00:00:55.388 -- 00:00:58.842 Dr. Alan Yang, our chief medical officer. and Dr. 00:00:58.842 -- 00:01:04.206 Jack West, Vice President and our Thoracic Oncology TA head. 00:01:05.389 -- 00:01:09.312 Before we get started with the rest of the call, I would like to note that some of the 00:01:09.312 -- 00:01:13.897 statements made by our management team and some responses to questions that we make today 00:01:13.897 -- 00:01:18.802 may be considered forward-looking statements based on our current expectations. 00:01:18.802 -- 00:01:23.686 Summit cautions that these forward-looking statements are subject to risks and uncertainties 00:01:23.686 -- 00:01:28.973 that may cause actual resu...